Objectives: Pharmaceutical, healthcare research

 

This presentation addresses the somewhat conflicting developments in healthcare research overrecent years - a move toward ever more innovative, consumer-driven research approaches, and the increase in ...

Over the past two decades clinical researchers have increasingly acknowledged the importance of their patients' attitudes in determining the outcomes of the therapies used to treat them. Being able to ...

Two-stage sampling has commonly been used in surveys of households and individuals. The standard strategy is first to stratify the frame population, then determine a reasonable number of primary sampl ...

Rationing of National Health Service expenditure is inevitable, difficult, controversial, and it is unusual for the public to have a direct say in setting healthcare spending priorities at the local l ...

Although today's clinical healthcare domain is typically driven by technological possibilities, increasingly awareness is building that a change in focus is needed to also incorporate the experiences ...

Consumers shop differently for OTC products than for their groceries. Advertising effectiveness, the relevance of shelf-based awareness, consumer 'buzz' and the role of the professional are key influe ...

This paper demonstrates the contribution of advanced qualitative research to the identification and exploration of non-rational responses and decision-making in the ethical and OTC fields of pharmaceu ...

Melanoma (a degenerative malignancy of the pigment-producing cells) is currently the fastest growing cancer worldwide, and is the most common cancer in young adults 20-30 years of age. When detected e ...

This paper examines how an ethnography study in two countries (USA and UK) helped a top 10 global pharmaceutical company radically revise how it thought about a medical condition and how clinical tria ...

As consumer healthcare costs escalate, the pharmaceutical industry continues to lose consumer trust. Pharmaceutical companies can reduce consumers' drug costs as a route to improving the industry's im ...

This paper is based upon the research findings of an independent study carried out to investigate the world of the modern healthcare consumer. Taking chronic back pain as an example condition, this pa ...

This paper seeks to provide some evidence on the return on investment of a website (eROI) using a longitudinal web survey methodology. Using data from 459 respondents, the results show that almost two ...

For many reasons hospitals have access restrictions that limit market research and data collection. This paper describes an alternative and efficient method to perform hospital market research using h ...

In the healthcare market pressures are beginning to force change, driven by two key influences. 1 . Prescription medicines in the same therapeutic classes are becoming more and more difficult to diffe ...

The paper presents a case study on a survey conducted online among 1,017 French GPs. The authors explain how this survey helped the client define its strategy to conquer its market by gaining a better ...

This paper sets the scene for discussion on a crucial topic: ‘Is market research enough to provide insight?’. Drawing on their own extensive experience as market researchers and business analysts for ...

This paper presents the results of a qualitative research study among diabetic patients that identifies distinct patient clusters based on existing attitudes and prevalent mindsets. Based on subsequen ...

A framework is presented to understand how consumers respond to eight topics for OTC health care, ranging from simple physical examinations to medicinal shampoo. The objective is to understand how con ...

This paper describes an independent study which examined the rate of return on investment for four of the most frequently used promotional tactics in the pharmaceutical industry. The areas covered we ...

The pharmaceutical industry follows a model where product brands stand alone and the company is not strongly linked to any specific prescription brand. This allows potential corporate protection shoul ...

Innovation in diagnosis, better understanding of disease prevention and continuous improved medications, in addition to an ageing population, are the cause of an ever-increasing market segment, namely ...

Longitudinal patient data has been cited as the largest single gap in healthcare data. This paper shows how a new, patent pending, patient-centric approach to data collection has been designed, using ...